Bipai Suan Jiaonang (吡哌酸胶囊)吡哌酸胶囊
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 西南药业股份有限公司Chinese legal name: 西南药业股份有限公司
主要成分Active Ingredients
- 吡哌酸Bipai Suan
药物知识说明
吡哌酸是一种在国家药监局注册认定的药品。该药品含有吡哌酸-f0d4d03c等成分。
该药品关联的活性成分包括：吡哌酸Bipai Suan。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：西南药业股份有限公司Chinese legal name: 西南药业股份有限公司。
您可以探索含有相同成分的其他药品：吡哌酸-f0d4d03c成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 吡哌酸胶囊) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 吡哌酸Bipai Suan.
Manufacturers recorded for this product: 西南药业股份有限公司Chinese legal name: 西南药业股份有限公司.
Explore other medicines containing the same ingredient: 吡哌酸 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 吡哌酸胶囊Recorded Chinese name: 吡哌酸胶囊
- 剂型Dosage form: 胶囊剂Capsules
- 规格Specification: 0.25g0.25 g
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 西南药业股份有限公司Chinese legal name: 西南药业股份有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H50020083
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H50020083
Manufacturer
Chinese legal name: 西南药业股份有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Protect from light and keep tightly closed.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H50020083
生产企业
西南药业股份有限公司(国产)
适应症
本品用于敏感菌革兰阴性杆菌所致的尿路感染、细菌性肠道感染。
用法用量
本品口服 。成人一次0.5g 一日1～2g。
不良反应
1.本品毒性较低，不良反应主要为恶心、嗳气、上腹不适、食欲减退、稀便或便秘等胃肠道反应，皮疹或全身瘙痒，少见：偶见眩晕、头痛、血清氨基转移酶一过性升高等。
2.上述不良反应均属轻微，停药后可自行恢复。
禁忌
禁用于对本品和萘啶酸过敏的患者。
注意事项
1.本品可与饮食同服，以减少胃肠道反应。
2.长期应用，宜定期监测血常规和肝、肾功能。
3.患中枢神经系统疾病者，如癫痫或癫痫病史者避免应用，确有指征应用时，宜在严密观察下慎用。
4.严重肝、肾功能减退者慎用。
贮藏
遮光，密封保存。
规格
0.25g
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.